Navigation Links
RPS Enhances Clinical Expertise and Leadership with Two Additions to Senior Management Team
Date:5/14/2008

FORT WASHINGTON, Pa., May 14 /PRNewswire/ -- RPS, Inc. today announced the addition of two new members to its Senior Management Team. David A. Green, Ph.D. joins RPS as Vice President of Clinical Operations. Neil H. Shusterman, M.D. joins RPS as Senior Vice President, Medical, Regulatory and Drug Safety.

"We are pleased that both Dr. David Green and Dr. Neil Shusterman have joined the RPS organization. Both individuals bring significant industry and drug development experience that will further enhance the depth and breadth of our clinical organizational leadership and expertise," said Harris Koffer, Pharm.D., President and Chief Operating Officer. "Under their leadership, I am confident that we will continue to expand our capabilities to provide innovative, global clinical development solutions to our customers."

David A. Green, Ph.D.

In his new role, Dr. Green will have oversight of Data Management, Statistics, Programming, Site Management and Monitoring, and Project Management.

Prior to joining RPS, Dr. Green held numerous positions of increasing scope and responsibility within the bio-pharmaceutical industry. Most recently, David served as Executive Director of Clinical Field Operations for Amgen, Inc. where he led the US Clinical Field Operations and oversaw field based trial operations across Phase I-III clinical trials and all therapeutic areas. During his tenure at Amgen he was also the Therapeutic Area Operations Lead for Diabetes/Obesity, Inflammation, and General Medicine.

David brings over 15 years of clinical trial operations experience in numerous therapeutic areas primarily associated with Oncology -- Supportive Care & Therapeutics, Diabetes/Obesity, Inflammation, General Medicine, Bone Metabolism, and HIV/AIDS. He brings extensive experience in the development and management of Clinical Field Operations, Clinical Trials Operations, and Clinical Drug Development in Phases I-III.

Neil H. Shusterman, M.D.

In his new role, Dr. Shusterman will have oversight of Medical, Regulatory Affairs, Medical Writing and Drug Safety Services.

Prior to joining RPS, Dr. Shusterman was Senior Vice President of Clinical Development at the Forest Research Institute of Forest Laboratories, Inc. At Forest Laboratories he also served as Senior Vice President, Clinical Development, Safety and Operations and Vice President, Internal Medicine Therapeutic Area, Clinical Development and Medical Affairs. Before joining Forest, Dr. Shusterman held the position of Vice President, Cardiovascular Therapeutic Area, North American Medical Affairs, R&D, at GlaxoSmithKline. He brings extensive knowledge and experience in clinical research and development, as well as therapeutic expertise in internal medicine, nephrology and cardiovascular medicine.

Additionally, Dr. Shusterman has served as an adjunct Assistant Professor in the Department of Medicine at the University of Pennsylvania's School of Medicine in Philadelphia, PA, and has held Administrative Appointments such as Chief Executive Officer, University of Pennsylvania Outpatient Dialysis Unit. He is board certified in Internal Medicine and Nephrology.

About RPS

RPS (ReSearch Pharmaceutical Services, Inc.), The Next Generation CRO, provides comprehensive global Phase I-IV clinical development solutions to the Pharmaceutical, Biotechnology and Medical Device industries. By combining an experienced clinical research operations infrastructure with the industry's largest resourcing engines, RPS is uniquely positioned to offer our clients both integrated and full service global outsourcing solutions.


'/>"/>
SOURCE ReSearch Pharmaceutical Services, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Kellogg School of Management Expert Finds Multicultural Experience Enhances Creativity
2. Study by Texas A&M University-Corpus Christi Confirms Training With Vision Software Enhances Hitting Skills
3. New VP of Operations Enhances The Beryl Companies Leadership Team
4. CAS New SciFinder(R) Enhances the Research Experience Via the Web
5. Avista Capital Partners Enhances Energy Practice With Appointment of Gerhard Kurz
6. Elsevier enhances clinical decision making with suite of Clinical Decision Support solutions
7. AT&T Enhances Performance for LAMMICO With Upgraded Network Services
8. Computer-Aided Detection in Screening Mammography Enhances Performance of a Single Reader
9. AGI Dermatics Data Indicates 8 Oxo-Guanine Repair Enzyme OGG1 Encapsulated in Liposomes, Reduces MMP-1, Increases Collagen and Enhances DNA Repair
10. Technique enhances digital television viewing for visually-impaired
11. Z-shaped incision enhances minimally invasive surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2017)... ... February 28, 2017 , ... Webster-Calhoun Cooperative Telephone Association (WCCTA) has sent out notices ... March 14th at 7:00 pm at the Southeast Valley High School Gymnasium located in Gowrie, ... Service" What do you look for in a company when you purchase a ...
(Date:2/28/2017)... ... 28, 2017 , ... Las Vegas Skin and Cancer Clinic (LVSCC) is proud ... 10, 2017, 4-7 pm PST. For more than six decades, LVSCC has provided the ... Rancho neighborhood, has been renovated to provide medical and cosmetic dermatological products and services. ...
(Date:2/28/2017)... Chicago, IL (PRWEB) , ... February 28, 2017 ... ... on Tuesday, March 7, 2017, from 4:30-5:30 p.m. at the 11th Annual RISE ... Stars, quality management, financial compliance, performance analytics, and engagement strategies. , The discussion ...
(Date:2/27/2017)... ... February 27, 2017 , ... Anahata Ananda ... Awakening, is happy to announce her “Spring Rejuvenation in Sedona” personally tailored ... customized retreats offer the winter-weary soul an excellent opportunity to come out of ...
(Date:2/27/2017)... Yorba Linda, Ca (PRWEB) , ... February 27, ... ... Coulter Life Sciences, provides an overview on laser diffraction analysis as a tool ... highlighting its capabilities, significance and potential to obtain improved results and novel scientific ...
Breaking Medicine News(10 mins):
(Date:2/28/2017)... ... and Markets has announced the addition of the "Rheumatoid Arthritis Drugs ... The latest research Rheumatoid Arthritis Drugs Price Analysis and Strategies ... Arthritis market. The research answers the following questions: ... and their clinical attributes? How are they positioned in the Global Rheumatoid ...
(Date:2/28/2017)... SAN FRANCISCO , February 27, 2017 ... D BioMedical assets for ...   LOI contemplates capital infusion into Amarantus ... value   Amarantus names four new appointees to its Board ... SeD Biomedical Inc. (SeD Biomedical) , ...
(Date:2/28/2017)... , Feb. 27, 2017  Market Research presents an all-encompassing ... fiber optics market titled ,Medical Fiber Optics Market: Global Industry ... and trends globally across the five key regions of ... , Europe , APAC and MEA which ... medical fiber optics market over the forecast period. In this ...
Breaking Medicine Technology: